Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma
University of Nebraska
University of Nebraska
Mayo Clinic
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)